VB-111 (ofranergene obadenovec) is an investigational targeted anti-cancer gene-therapy that uses a dual mechanism to target solid tumors.
https://www.google.com/url?rct=j&sa=t&url=https://finance.yahoo.com/news/vascular-biogenics-ovarian-cancer-gene-180810590.html&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNEHDklnB0bBwyiOlpR6BSuuWdHF1A
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.